JP2006522775A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006522775A5 JP2006522775A5 JP2006505540A JP2006505540A JP2006522775A5 JP 2006522775 A5 JP2006522775 A5 JP 2006522775A5 JP 2006505540 A JP2006505540 A JP 2006505540A JP 2006505540 A JP2006505540 A JP 2006505540A JP 2006522775 A5 JP2006522775 A5 JP 2006522775A5
- Authority
- JP
- Japan
- Prior art keywords
- het
- group
- alkyl
- phenyl
- imidazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP0303879 | 2003-04-11 | ||
| PCT/EP2004/050492 WO2004089372A1 (en) | 2003-04-11 | 2004-04-08 | Substituted 4-phenyl-4-`1h-imidazol-2-yl !-piperidine derivatives and their use as selective non-peptide delta opioid agonists with antidepressant and anxiolytic activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006522775A JP2006522775A (ja) | 2006-10-05 |
| JP2006522775A5 true JP2006522775A5 (https=) | 2007-06-07 |
Family
ID=33154992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006505540A Withdrawn JP2006522775A (ja) | 2003-04-11 | 2004-04-08 | 置換された４−フェニル−４−’１ｈ−イミダゾール−２−イル！−ピペリジン誘導体および抗抑鬱および不安緩解活性を有する選択性非ペプチドデルタオピオイドアゴニストとしてのそれらの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20060287345A1 (https=) |
| EP (1) | EP1615644B1 (https=) |
| JP (1) | JP2006522775A (https=) |
| AR (1) | AR044010A1 (https=) |
| AT (1) | ATE353649T1 (https=) |
| AU (1) | AU2004228960A1 (https=) |
| CA (1) | CA2521186A1 (https=) |
| CL (1) | CL2004000754A1 (https=) |
| DE (1) | DE602004004771T2 (https=) |
| ES (1) | ES2282858T3 (https=) |
| TW (1) | TW200509913A (https=) |
| WO (1) | WO2004089372A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1390848B1 (it) | 2008-07-31 | 2011-10-19 | Neuroscienze Pharmaness S C A R L | Composti farmaceutici |
| EP2149370A1 (en) | 2008-07-31 | 2010-02-03 | Neuroscienze Pharmaness S.C. A R.L. | Diazabicyclic compounds and microemulsions thereof |
| JP2011030565A (ja) * | 2009-07-06 | 2011-02-17 | Yokohama City Univ | 社会的隔離モデル動物 |
| IT1396951B1 (it) | 2009-12-18 | 2012-12-20 | Neuroscienze Pharmaness S C A R L | Composti farmaceutici |
| CA2911231C (en) * | 2013-05-24 | 2021-12-07 | Alkermes Pharma Ireland Limited | Morphan and morphinan analogues, and methods of use |
| CN113292559B (zh) | 2015-03-17 | 2024-04-02 | 日本化学药品株式会社 | 吗啡喃衍生物 |
| US20210371422A1 (en) | 2016-08-09 | 2021-12-02 | Nippon Chemiphar Co., Ltd. | Morphinan derivative |
| US11633392B2 (en) | 2016-09-16 | 2023-04-25 | Nippon Chemiphar Co., Ltd. | Use of morphinan derivative for therapeutic treatment of opioid delta receptor agonist-related disease |
| MA52482B1 (fr) | 2018-05-01 | 2024-12-31 | Merck Sharp & Dohme Llc | Dérivés de spiropipéridine en tant que modulateurs allostériques des récepteurs nicotiniques de l'acétylcholine |
| AU2020385852A1 (en) | 2019-11-22 | 2022-06-02 | Nippon Chemiphar Co., Ltd. | Pyrazolomorphinan derivative |
| CA3211977A1 (en) | 2021-02-26 | 2022-09-01 | Tokyo University Of Science Foundation | Pharmaceutical composition for treatment or prevention of stress-related disorders |
| US20220305020A1 (en) * | 2021-03-26 | 2022-09-29 | Ingenious Ingredients, LP | The use of paraxanthine to reduce exercise-induced mental fatigue |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5354863A (en) * | 1992-01-21 | 1994-10-11 | G. D. Searle & Co. | Opioid agonist compounds |
| DE19805370A1 (de) * | 1997-03-14 | 1998-09-17 | Gruenenthal Gmbh | Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen |
| HN1999000149A (es) * | 1998-09-09 | 2000-01-12 | Pfizer Prod Inc | Derivados de 4,4-biarilpiperidina |
| EP1038872A1 (en) * | 1999-02-22 | 2000-09-27 | Pfizer Products Inc. | 4-Phenyl-4-heteroarylpiperdine derivatives as opioid receptor ligands |
| DE19939044A1 (de) * | 1999-08-18 | 2001-03-15 | Gruenenthal Gmbh | Verwendung von Morphinanderivaten als Arzneimittel |
| SE0101767D0 (sv) * | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
| BR0213325A (pt) * | 2001-10-15 | 2004-10-13 | Janssen Pharmaceutica Nv | Derivados de 4-fenil-4-[1h-imidazol-2-il]-piperidina substituìda para a redução de dano isquêmico |
| EA006507B1 (ru) * | 2001-10-15 | 2005-12-29 | Янссен Фармацевтика Н.В. | Новые замещенные 4-фенил-4-[1h-имидазол-2-ил] пиперидиновые производные и их применение в качестве селективных непептидных агонистов дельта-опиоидов |
-
2004
- 2004-04-07 CL CL200400754A patent/CL2004000754A1/es unknown
- 2004-04-07 AR ARP040101193A patent/AR044010A1/es not_active Application Discontinuation
- 2004-04-08 DE DE602004004771T patent/DE602004004771T2/de not_active Expired - Fee Related
- 2004-04-08 ES ES04726520T patent/ES2282858T3/es not_active Expired - Lifetime
- 2004-04-08 EP EP04726520A patent/EP1615644B1/en not_active Expired - Lifetime
- 2004-04-08 US US10/552,527 patent/US20060287345A1/en not_active Abandoned
- 2004-04-08 AU AU2004228960A patent/AU2004228960A1/en not_active Abandoned
- 2004-04-08 CA CA002521186A patent/CA2521186A1/en not_active Abandoned
- 2004-04-08 JP JP2006505540A patent/JP2006522775A/ja not_active Withdrawn
- 2004-04-08 WO PCT/EP2004/050492 patent/WO2004089372A1/en not_active Ceased
- 2004-04-08 AT AT04726520T patent/ATE353649T1/de not_active IP Right Cessation
- 2004-04-09 TW TW093109827A patent/TW200509913A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2437882C2 (ru) | Производные имидазолидинона | |
| JP2009541311A5 (https=) | ||
| JP2022189853A5 (https=) | ||
| JP2006522775A5 (https=) | ||
| JP2008513514A5 (https=) | ||
| JP2012501312A5 (https=) | ||
| JP2011500806A5 (https=) | ||
| CA2642922A1 (en) | Melanocortin type 4 receptor agonist piperidinoylpyrrolidines | |
| RU2015150946A (ru) | Новые соединения для селективных ингибиторов гистондеацетилазы и фармацевтическая композиция, включающая такие соединения | |
| JP2019530695A5 (https=) | ||
| EA018268B1 (ru) | Аналоги пиридона и пиридазона как модуляторы gpr119 | |
| RU2008126398A (ru) | Производные гетероарилзамещенного пиперидина в качестве ингибиторов печеночной карнитин пальмитоилтрансферазы (l-cpti) | |
| PE20081228A1 (es) | Compuesto heteromonociclico | |
| JP2019513776A5 (https=) | ||
| JP2018530591A5 (https=) | ||
| RU2018138047A (ru) | Гетероциклические вещества - агонисты gpr119 | |
| RU2008117329A (ru) | Производные имидазопиридина как антагонисты аденозинового рецептора а2в | |
| SI2855449T1 (en) | SULFONYL PIPERIDIN DERIVATIVES AND THEIR USE IN TREATMENT OF PROKINETICINAL DISEASE DISEASES | |
| EP2594270A2 (en) | The use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc) | |
| JP2014521623A5 (https=) | ||
| HRP20140252T1 (hr) | Derivati imidazola kao inhibitori kazeinske kinaze | |
| HRP20161797T1 (hr) | Spojevi 1,3-oksazolidina ili 1,3-oksazinana kao antagonisti receptora oreksina | |
| PE20081315A1 (es) | Derivados de benzimidazol como antagonistas de vr-1 | |
| CA2905530A1 (en) | Pyrrolo[2,3-b]pyridine cdk9 kinase inhibitors | |
| CA2462953A1 (en) | Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |